Glaukos march 2018 ir presentation 03012018 | PPT
Glaukos Corp's President & COO Joseph Gilliam Sells 9,476 Shares
Why Glaukos Stock Jumped 16.3% in February | The Motley Fool
Glaukos Co. Expected to Earn Q1 2025 Earnings of ($0.47) Per Share (NYSE:GKOS) - Defense World
GKOS - Glaukos Corporation Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)
Glaukos Vs CryoLife Market Cap (2014-2023)
Why Glaukos Corporation (NYSE:GKOS) Could Be Worth Watching
Glaukos Corporation | GKOS - Stock Price Today
Glaukos (GKOS) - undefined - 16 Stock Buys For 2017
Glaukos Vs CryoLife Market Cap (2014-2023)
Glaukos (GKOS) - Market capitalization
Glaukos Vs CryoLife Market Cap (2014-2023)
Here's Why You Should Retain Glaukos (GKOS) Stock for Now - February 14, 2024 - Zacks.com
Glaukos: Assessing The Value Proposition After Multiple Recent Deals (NYSE:GKOS) | Seeking Alpha
Assessing Glaukos (GKOS)'s Market Valuation: Is the Price Just R
Glaukos stock jumps 15% on FDA approval of glaucoma drug (NYSE:GKOS) | Seeking Alpha
Buy Glaukos Stock - GKOS Stock Price Today & News - Public.com
JP Morgan Upgrades Glaukos (GKOS)
Glaukos Stock (NYSE:GKOS), Quotes and News Summary - Benzinga
Glaukos (GKOS) analysts target $55.89 (down -10.69%) | wallmine
Glaukos Corp (GKOS) Reports Increased Sales but Widening Losses in Q4 and Full Year 2023
Glaukos Corporation (GKOS) Stock Price, Quote, News & Analysis
Glaukos Corporation Shares Fall 10.5% Below Previous 52-Week Low - Market Mover | Nasdaq
Glaukos' (GKOS) iDose TR Gets FDA Nod for Glaucoma Treatment - December 19, 2023 - Zacks.com
